patient

Anthony M. Hunter, MD, is an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A hematologist, Dr. Hunter specializes in treating patients with leukemia and other myeloid malignancies including myeloproliferative neoplasms, myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Dr. Hunter holds professional memberships with American Society of Clinical Oncology, American Society of Hematology, and Society of Hematologic Oncology. Dr. Hunter received his Medical Degree from Medical College of Wisconsin in

Dr. Eunice Wang is the Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center. Dr. Wang joined the Roswell Park faculty in 2003 and was appointed to the Leukemia Service of the Department of Medicine. She earned her medical degree from the Keck School of Medicine, University of Southern California and completed residency training in Internal Medicine at Yale-New Haven Hospital, Yale University, New Haven, CT in 1999. From 1999 to 2003, she completed a clinical hematology-oncology and research fellowship at Memorial Sloan Kettering Cancer Center in New York, NY. She is

As a physician caring for patients with acute leukemias and related disorders, I have a sustained focus on translational research in hematologic malignancies. Genomic sequencing technology revolutionized our understanding of cancer biology. My research focuses on exploring the dynamic changes of tumor immune microenvironment with clonal evolution of myeloid malignancies. Targeting inflammaging of bone marrow to impede clonal evolution is my ultimate professional goal and there by improve the survival rate for leukemia patients. My long-term goal is to develop potentially less toxic targeted

Dr. Elizabeth Bowhay-Carnes is a Texas native and passionate about serving the people of her home community. She earned her bachelors of science degree in biochemistry from the University of Texas at Austin, followed by work with the MD Anderson Cancer Center Umbilical Cord Blood Bank in Houston. She received her medical doctorate from UT Health San Antonio and completed her residency in internal medicine and fellowship in hematology and medical oncology at the UT Health Science Center. She joined UT Health San Antonio MD Anderson Cancer Center in 2016 as Director of the Adult Non-Malignant

Dr. Lai's clinical expertise is in Blood and Marrow Transplantation (BMT). She specializes in autologous and allogeneic hematopoietic cell transplants for the treatment of malignant and benign hematologic diseases in adult patients. She conducts her research in the Medicine Division of Hematology/BMT at the Huntsman Cancer Center. She specializes in detecting, monitoring, and treating acute leukemias and myeloid malignancies in adults. Previously at the National Institutes of Health (NIH) and Medstar Georgetown University Hospital, she focused on clinical trials in acute leukemias.